Specifications
- Purity
- ≥97% (HPLC)
- Identity
- 1H-NMR
- Appearance
- White to off-white powder
Properties
- Solvents
- toluene, DMSO (10 mg/ml), DMF
Available from stock
Flumequine
- SKU
- F0079
Category: Antibiotics
- Synonyms
- 9-Fluoro-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid
- 42835-25-6
- CAS-Number
- C14H12FNO3
- Molecular Formula
- 261.3
- Molecular Weight
- Short Term Storage
- +4°C
- Use / Stability
- Stable for at least 2 years after receipt when stored at -20°C.
- Handling Advice
- Protect from light and moisture.
- Long Term Storage
- -20°C
- Shipping
- AMBIENT
- Transportation
- Not dangerous goods
- Description
- Flumequine is a fluoroquinolone synthetic chemotherapeutic antibiotic used to treat bacterial infections. Targets primarily gram negative bacteria, especially those which cause enteric infections in animals. It is used to study processes that affect mammalian chromosome and DNA unwinding at the level of gyrase/topoisomerases. It inhibits topoisomerases, which are needed for the transcription and replication of bacterial DNA. The inhibition of the topoisomerases results in strand breakage of the bacterial chromosome, supercoiling and resealing. Therefore, DNA replication and transcription is inhibited. It was also used to study hepatocarcinogenicity and DNA damage in mice and the mechanisms of quinolone resistance.
- InChi
- InChI=1S/C14H12FNO3/c1-7-2-3-8-4-9(15)5-10-12(8)16(7)6-11(13(10)17)14(18)19/h4-7H,2-3H2,1H3,(H,18,19)
- References
- (1) G. Stilwell, et al.: Antimicrob. Agents Chemother. 7, 483 (1975) , (2) S.R. Rohlfing, et al.: J. Antimicrob. Chemother. 3, 615 (1977) , (3) M. Yoshida, et al.: Cancer Lett. 141, 99 (1999) , (4) A. Ruiz-Garcia, et al.: Eur. J. Pharm. Biopharm. 48, 253 (1999) , (5) Y. Kashida, et al.: Toxicol. Sci. 69, 317 (2002) , (6) Y. Kuroiwa, et al.: Arch. Toxicol. 81, 63 (2007)
- InChi Key
- DPSPPJIUMHPXMA-UHFFFAOYSA-N
- Smiles
- CC1CCC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2
Flumequine is a fluoroquinolone synthetic chemotherapeutic antibiotic used to treat bacterial infections. Targets primarily gram negative bacteria, especially those which cause enteric infections in animals. It is used to study processes that affect mammalian chromosome and DNA unwinding at the level of gyrase/topoisomerases. It inhibits topoisomerases, which are needed for the transcription and replication of bacterial DNA. The inhibition of the topoisomerases results in strand breakage of the bacterial chromosome, supercoiling and resealing. Therefore, DNA replication and transcription is inhibited. It was also used to study hepatocarcinogenicity and DNA damage in mice and the mechanisms of quinolone resistance.
Zusätzliche Information
| Synonyms | 9-Fluoro-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid |
|---|---|
| Purity | ≥97% (HPLC) |
| Appearance | White to off-white powder |
| CAS-Number | 42835-25-6 |
| Molecular Formula | C14H12FNO3 |
| Molecular Weight | 261.3 |
| Identity | 1H-NMR |
| Solvents | toluene, DMSO (10 mg/ml), DMF |
| Smiles | CC1CCC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2 |
| InChi Key | DPSPPJIUMHPXMA-UHFFFAOYSA-N |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light and moisture. |
| Use / Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Transportation | Not dangerous goods |
| References | (1) G. Stilwell, et al.: Antimicrob. Agents Chemother. 7, 483 (1975), (2) S.R. Rohlfing, et al.: J. Antimicrob. Chemother. 3, 615 (1977), (3) M. Yoshida, et al.: Cancer Lett. 141, 99 (1999), (4) A. Ruiz-Garcia, et al.: Eur. J. Pharm. Biopharm. 48, 253 (1999), (5) Y. Kashida, et al.: Toxicol. Sci. 69, 317 (2002), (6) Y. Kuroiwa, et al.: Arch. Toxicol. 81, 63 (2007) |
| InChi | InChI=1S/C14H12FNO3/c1-7-2-3-8-4-9(15)5-10-12(8)16(7)6-11(13(10)17)14(18)19/h4-7H,2-3H2,1H3,(H,18,19) |
| Quantity | 5 g, 25 g, Bulk |
